NCT02965703 2026-03-18
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
13 trialsNCT06728072 2026-02-09
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Virginia Commonwealth University
Phase 2 Recruiting
NCT05411718 2025-11-13
A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT02521285 2025-10-23
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04534218 2024-12-20
REPROGRAM-01
Centre Hospitalier Universitaire de Besancon
Phase 2 Completed
NCT05637567 2023-11-13
ASAP
German Cancer Research Center
Phase 2 Not yet recruiting
NCT00578721 2023-07-07
Trial of Aspirin and Arginine Restriction in Colorectal Cancer
University of California, Irvine
Phase 2 Completed
NCT05402124 2022-06-02
The Colorectal Cancer Chemoprevention Acceleration and Improvement Platform (CRC-CHAMP) Study
University of Calgary
Phase 2 Unknown
NCT03170115 2020-12-17
ICAR
Instituto Nacional de Cancer, Brazil
Phase 2 Terminated
NCT00468910 2017-05-31
Aspirin in Preventing Colorectal Cancer in Patients at Increased Risk of Colorectal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT02602938 2015-11-13
ACABC
Zhejiang Provincial People's Hospital
Phase 2 Unknown
NCT00474903 2014-07-02
Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
National Cancer Institute (NCI)
Phase 2 Completed
NCT00062023 2012-07-30
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Terminated